Senate Democrats urge abortion pill maker to add miscarriage management to label

Published



Senate Democrats are urging one of the manufacturers of the abortion pill mifepristone to update the drug’s labeling to make it easier for patients to access the medication to reduce complications from a miscarriage in states with restrictive abortion laws.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.